Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
192M
-
Number of holders
-
307
-
Total 13F shares, excl. options
-
147M
-
Shares change
-
+6.99M
-
Total reported value, excl. options
-
$10B
-
Value change
-
+$474M
-
Put/Call ratio
-
1.41
-
Number of buys
-
156
-
Number of sells
-
-141
-
Price
-
$68.21
Significant Holders of BIOMARIN PHARMACEUTICAL INC - COM (BMRN) as of Q1 2014
369 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - COM as of Q1 2014.
BIOMARIN PHARMACEUTICAL INC - COM (BMRN) has 307 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 147M shares
of 192M outstanding shares and own 76.52% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (17.8M shares), SANDS CAPITAL MANAGEMENT, LLC (9.74M shares), PRIMECAP MANAGEMENT CO/CA/ (8.16M shares), VANGUARD GROUP INC (8.03M shares), JENNISON ASSOCIATES LLC (8.02M shares), FMR LLC (7.3M shares), Winslow Capital Management, LLC (4.82M shares), State Street Corp (3.89M shares), BlackRock Institutional Trust Company, N.A. (3.47M shares), and WELLS FARGO & COMPANY/MN (3.47M shares).
This table shows the top 307 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.